Skip to content

Bone health in professional cycling

Bone health in professional cycling - Bone health and cycling

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON52815
Enrollment
75
Registered
2020-05-14
Start date
2020-10-01
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

botgezondheid Bone health osteoporosis

Interventions

None listed

Sponsors

Hogeschool van Arnhem en Nijmegen
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Male and female (18y+) Professional cyclist competing in UCI*s WorldTour competition or a talent of that team. Former professional cyclists (35y+) Willing to give written informed consent. Willing to comply with study procedures.

Exclusion criteria

Exclusion criteria: Having a history of medical events or medication use that may significantly affect bone metabolism, to be decided by the principal investigator. Medication use that may affect tests within this study must be minimal 3 months before Day 01 of this study. Participation in any clinical trial including blood sampling and/or administration of substances up to 30 days before Day 01 of this study A recent injury that may significantly affect BMD, to be decided by the principal investigator. Participants who have had a traumatic fracture recently (

Design outcomes

Primary

MeasureTime frame
Bone health: whole body and regional (lumbar spine and femoral hip) bone mineral density and bone mineral content as determined by dual-energy X-ray absorptiometry (DXA).

Secondary

MeasureTime frame
Cycling exercise volume during the preceding 12 months (for retired cyclists we obtain the average volume during a 5 year period in their career). Dietary intake (energy, macronutrients, calcium, vitamin D) Blood parameters of bone health: Procollagen type I N propeptide (PINP), carboxy-terminal crosslinking telopeptide of type I collagen (CTX-I), calcitonine, parathyroid hormone (PTH), testosterone oestrogen. History of sports participation during life. Bone microarchitecture and bone strength will be assessed by HR-pQCT. A scan takes ~2 minutes, is painless, non-invasive and involves only low radiation exposure (effective radiation dose of ~5 µSv).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 16, 2026